Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    16899777 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method
2 Terminated
Has Results
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Vinorelbine followed by Cisplatin;   Drug: Pemetrexed followed by Cisplatin
3 Unknown  Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Procedure: conventional surgery
4 Terminated
Has Results
Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Dasatinib

Indicates status has not been verified in more than two years